CADL - What's Going On With Candel Therapeutics Stock On Friday? | Benzinga
Friday, Candel Therapeutics Inc (NASDAQ:CADL) shares are trading higher on heavy volume with a session volume of 7.89 million versus the average volume of 2.37 million, as per data from Benzinga Pro.
Candel Therapeutics shares are trading higher on continued strength after the company announced interim data from the randomized phase 2 clinical trial of CAN-2409 in non-metastatic pancreatic cancer on Thursday.
Prolonged and sustained survival was observed after experimental treatment with CAN-2409 in patients with ...